Testing effectiveness (Phase 2)Study completedNCT01496131What this trial is testingTecemotide (L-BLP25) in Prostate CancerWho this might be right forProstate Cancer EMD Serono 28
Not applicableActive Not RecruitingNCT05269550What this trial is testingPSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER)Who this might be right forProstate Cancer London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 50
Not applicableLooking for participantsNCT05754580What this trial is testingHigh-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate CancerWho this might be right forProstatic Cancer University of Nebraska 53
Testing effectiveness (Phase 2)Ended earlyNCT02805894What this trial is testingNBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate AdenocarcinomaWho this might be right forProstate Cancer Nanobiotix 5
Large-scale testing (Phase 3)Study completedNCT00002723What this trial is testingLow, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI) 390
Not applicableUnknownNCT04045756What this trial is testingFocal Laser Ablation for the Treatment of Focal Low-Intermediate Risk Prostate CancerWho this might be right forProstate Cancer University of Rome Tor Vergata 50
Testing effectiveness (Phase 2)Looking for participantsNCT07751159What this trial is testingRadiation Therapy Approaches for People With Prostate CancerWho this might be right forProstate Cancer PatientsNon-metastatic Prostate CancerHigh Risk Prostate Cancer Memorial Sloan Kettering Cancer Center 126
Testing effectiveness (Phase 2)Study completedNCT02280356What this trial is testingRadiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 45
Large-scale testing (Phase 3)Active Not RecruitingNCT02692105What this trial is testingComparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate CancerWho this might be right forProstate Cancer British Columbia Cancer Agency 60
Not applicableEnded earlyNCT02454517What this trial is testingDiet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate CancerWho this might be right forProstate AdenocarcinomaStage I Prostate Cancer AJCC V7Stage IIA Prostate Cancer AJCC v7 Fred Hutchinson Cancer Center 117
Early research (Phase 1)Study completedNCT02693860What this trial is testingNeoadjuvant J591 Treatment for Prostate CancerWho this might be right forProstate Cancer Weill Medical College of Cornell University 8
Testing effectiveness (Phase 2)Study completedNCT03322020What this trial is testingAndrogen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Prostate CancerWho this might be right forNeoplasm, Prostate Asan Medical Center 30
Not applicableActive Not RecruitingNCT05683691What this trial is testingWater Vapor Ablation for Localized Intermediate Risk Prostate CancerWho this might be right forProstate Cancer Francis Medical Inc. 400
Testing effectiveness (Phase 2)Study completedNCT02649790What this trial is testingStudy of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer IndicationsWho this might be right forRelapsed/Refractory Multiple Myeloma (RRMM)Metastatic Colorectal Cancer (mCRC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more Karyopharm Therapeutics Inc 277
Large-scale testing (Phase 3)UnknownNCT00653848What this trial is testingAdjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical RadiotherapyWho this might be right forProstate Cancer Scandinavian Prostate Cancer Group 378
Testing effectiveness (Phase 2)Study completedNCT02499848What this trial is testingEvaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate CancerWho this might be right forProstate Cancer Sophiris Bio Corp 18
Not applicableLooking for participantsNCT07407608What this trial is testingABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0Who this might be right forProstate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer Non-Metastatic University of Milano Bicocca 58
Early research (Phase 1)Active Not RecruitingNCT02023463What this trial is testingEnzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate CancerWho this might be right forAdenocarcinoma of the ProstateRecurrent Prostate CancerStage IIB Prostate Cancer+2 more Thomas Jefferson University 25
Testing effectiveness (Phase 2)Looking for participantsNCT05851547What this trial is testingDose Escalation For INtraprostatic LEsionsWho this might be right forProstatic Neoplasms Ottawa Hospital Research Institute 54
Not applicableLooking for participantsNCT06027892What this trial is testingTwo-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate CancerWho this might be right forPROSTATE CANCER Rabin Medical Center 562